Proximity Ligation Assay
Proximity Ligation Assay (PLA) is a method for detecting protein protein interactions, post translational modifications, or close spatial proximity (within about 40 nanometers) directly in fixed cells or tissues with single molecule sensitivity. This guide is for experimental biologists, cell biologists, and translational researchers who want a practical framework for designing, executing, and interpreting PLA experiments. The NCBI Bookshelf provides foundational reference material on molecular detection techniques, and EMBL EBI Training offers structured protocols for proximity based assays. PLA bridges the gap between traditional co immunoprecipitation and super resolution microscopy by combining antibody specificity with rolling circle amplification to generate a discrete fluorescent dot for each detected interaction pair.
At a Glance
| Aspect | Key Information |
|---|---|
| Purpose | Visualize protein protein interactions, protein modifications, or close proximity in fixed samples |
| Principle | Two primary antibodies with DNA conjugated secondary antibodies, ligation of DNA probes when within 40 nm, rolling circle amplification |
| Detection | Fluorescence microscopy, bright punctate signal per interaction event |
| Resolution | Single molecule sensitivity within a diffraction limited spot |
| Sample types | Cultured cells, tissue sections, cryosections, formalin fixed paraffin embedded (FFPE) samples |
| Typical applications | Protein complex validation, receptor dimerization, kinase substrate proximity, post translational modification crosstalk |
| Key limitations | Not live cell compatible, requires careful controls for antibody specificity, proximity does not prove direct binding |
Decision Criteria for Using PLA
You should consider PLA when your question involves detecting whether two molecules coexist within a small enough space to imply functional interaction. A recent study on protein interfaces in cancer used PLA to validate TNKS USP25 interactions in cell models, demonstrating how the assay can confirm targets identified by structural biology RSC Advances 42441110. PLA excels over co immunoprecipitation because it preserves spatial context and can detect transient or weak interactions that might be lost during lysis. It also outperforms Förster resonance energy transfer (FRET) in terms of flexibility because it does not require genetic fusion of fluorescent proteins. However, PLA requires fixed samples so it cannot capture dynamic changes in real time.
Choose PLA when you need to:
- Map interaction partners within a specific subcellular compartment
- Confirm proximity between endogenous proteins without overexpression
- Assess interaction frequency across a population of cells
- Detect protein modifications in close association with another protein
Avoid PLA when you need live cell kinetics, when antibodies are not validated for fixed samples, or when you require absolute quantification of binding affinity. A study on extracellular vesicles and particles in early stage lung adenocarcinoma used PLA to detect protein complexes on the surface of vesicles, illustrating the assay's power for non conventional sample types Scientific Reports 42436159. Always consider whether your target proteins are expected to be within 40 nm. If they are known to interact indirectly through a large complex, PLA may give a false negative due to distance.
Practical Workflow for PLA
The following workflow is adapted from standard protocols described in training resources like those from Galaxy Training Network for image analysis, though the wet lab steps are documented across multiple sources. Plan for at least two days from fixation to imaging.
Sample preparation and fixation. Use 4% paraformaldehyde (PFA) for most cultured cells. For tissue sections, follow optimized protocols for antigen retrieval. Permeabilize with Triton X 100 or saponin depending on the target location. Block with a buffer containing normal serum to prevent non specific antibody binding.
Primary antibody incubation. Choose two well validated antibodies from different species (e.g., rabbit and mouse). Titrate each antibody independently to determine the optimal concentration that gives low background. Incubate overnight at 4 degrees Celsius. Include a negative control where one primary antibody is omitted.
Proximity probes incubation. Add PLA probes which are secondary antibodies conjugated with short DNA oligonucleotides. One probe carries a plus strand and the other a minus strand. Incubate for 1 hour at 37 degrees Celsius. Wash thoroughly to remove unbound probes.
Ligation. Add a ligation solution containing a connector oligonucleotide and DNA ligase. If the two probes are within approximately 40 nanometers, the hybridized DNA strands can be joined to form a circular DNA template. Incubate for 30 minutes at 37 degrees Celsius.
Rolling circle amplification. Add nucleotides and a DNA polymerase to initiate rolling circle amplification. The polymerase extends around the circular template many times, generating a long single stranded DNA product that remains tethered to the original interaction site. This step takes about 100 minutes.
Detection. Hybridize fluorescently labeled oligonucleotide probes to the amplified DNA product. Each interaction event now appears as a bright punctate spot under a fluorescence microscope. Use appropriate excitation and emission filters. For analysis, capture at least 20 random fields per condition.
Image analysis. Segment nuclei and cells, count PLA dots per cell or per area, and quantify dot intensity as a secondary measure. Open source tools like those in Bioconductor can automate dot counting from high content images, though manual validation is recommended for complex tissue samples.
Data normalization. Express results as dots per cell or dots per area relative to a control condition. Do not report absolute dot numbers as exact counts of interactions because amplification efficiency may vary.
A study on IP3 receptor TRPM4 coupling in pericytes used PLA to confirm the spatial relationship between these two channels in capillary constriction, showing how the method can validate proximity in functional tissue contexts bioRxiv 42427718. That work included careful controls to demonstrate signal specificity.
Quality Checks and Controls
Every PLA experiment requires a set of controls to distinguish true proximity signals from background. Include at least the following:
- Negative control 1: Omit one primary antibody. No PLA dots should appear above background.
- Negative control 2: Use cells that do not express one of the target proteins (if available). This controls for off target probe binding.
- Positive control: Use a known interaction pair with validated proximity (e.g., two subunits of a well characterized complex). This confirms the assay chemistry is working.
- Single antibody control: Use both primary antibodies but test each separately with the full PLA probe set. This rules out that one antibody alone generates signal through non specific probe bridging.
- Ligase omission control: Omit ligase in the ligation step. No amplification should occur.
- Cell type control: If using tissue sections, include a slide from a knockout or knock down condition if possible.
A study on AMPK gamma 2 interactions with myosin in cardiac hypertrophy used PLA with appropriate controls to validate the physical association, and raw data are often deposited in public repositories like the NCBI Sequence Read Archive for transparency, especially when combined with RNA sequencing.
Monitor for the following quality indicators during analysis:
- Dot size is uniform across the field (typically 0.5 to 1.0 micron after amplification).
- Background signal in the negative control is less than 5 percent of the signal in the test condition.
- Dot distribution matches expected subcellular localization (e.g., nuclear dots for nuclear interactions, cytoplasmic for cytoplasmic).
Common Mistakes
Using poorly validated antibodies. PLA amplifies any signal from antibody binding, including off target binding. Always validate each antibody by western blot or immunofluorescence before starting PLA. A non specific antibody will produce false positive dots. A study on MFN2 mediated mitochondria endoplasmic reticulum contacts in odontoblasts used well characterized antibodies for PLA, emphasizing the need for antibody validation Journal of Dental Research 42421512.
Inadequate washing between steps. Residual unbound probes can ligate and amplify in solution, creating diffuse background. Follow the recommended wash buffer and incubation times. Do not reduce wash steps to save time.
Choosing the wrong distance threshold. PLA only works when the two DNA probes are within about 40 nm. If your protein complex has a large conformational change or if the epitopes are far apart on the same complex, you may get a false negative. Consider using antibodies that bind to different domains of the same protein as a positive control for proximity.
Overinterpretation of dot intensity. The intensity of each dot depends on amplification efficiency, not on the number of interaction events at that site. A brighter dot does not mean a stronger binding affinity. Count dots, not integrated intensity, for quantification.
Ignoring batch effects. PLA signal can vary between experiments due to differences in fixation, permeabilization, or reagent age. Always include the same control condition in every experiment. Normalize results to that control.
Limits of Interpretation
PLA reports proximity, not direct binding. Two proteins within 40 nm may be part of the same complex but not necessarily touching each other. A third adaptor protein could mediate the proximity. To claim direct interaction, you need complementary methods such as crosslinking mass spectrometry or surface plasmon resonance.
The spatial resolution of PLA is approximately 40 nm, but the amplified dot spreads over 0.5 to 1.0 micron during rolling circle amplification. Therefore, PLA cannot resolve the exact position of the interaction within a large complex. You cannot deduce atomic level details.
Quantification should remain relative rather than absolute. The number of dots per cell depends on antigen accessibility, antibody affinity, ligation efficiency, and amplification efficiency. You cannot convert dots directly to a binding constant or stoichiometry. Use PLA to compare conditions (e.g., treatment vs control) rather than to measure absolute interaction frequency.
A study targeting CH25H to boost p62 dependent autophagic degradation of alpha synuclein in Parkinson disease models used PLA in combination with other assays to confirm proximity, showing the value of multipronged validation Science Translational Medicine 42418556. The authors did not rely solely on PLA for mechanistic claims.
PLA is not compatible with live cell imaging. The fixation, permeabilization, and multiple washing steps destroy membrane integrity and kill cells. Use complementary methods such as bimolecular fluorescence complementation or FRET for live cell studies.
Background in tissue sections can be high due to autofluorescence, endogenous biotin, or tissue debris. Perform spectral unmixing or use far red fluorophores to reduce background. Always compare matched tissue types from control and experimental groups.
Frequently Asked Questions
Q1: Can PLA detect transient protein interactions? Yes, as long as the interaction state is preserved by fixation. PLA can capture weak or transient interactions that may be lost during cell lysis for co immunoprecipitation. However, the fixation itself may crosslink interacting proteins and also create artificial proximity if cells are overfixed. Optimize fixation time carefully.
Q2: What is the optimal distance for PLA to work? The DNA probes must be within approximately 40 nanometers for the connector oligonucleotide to bridge and allow ligation. If your target proteins are part of a large complex with epitopes farther apart, choose different antibody pairs that bind closer to the interaction interface. Pilot experiments with known positive controls help determine whether your antibody combination works.
Q3: Can I use PLA to study more than two proteins? Standard PLA detects two targets. Multiplexed PLA exists using different fluorophore detection probes, but it requires careful spectral separation and additional controls. Most researchers perform sequential PLA on the same sample or use PLA followed by conventional immunofluorescence for a third target.
Q4: How do I quantify PLA signals from tissue sections? Use automated image analysis software that can detect dots based on size and intensity thresholds. Count dots per cell or dots per unit area. For tissue sections, ensure that you compare equivalent regions (e.g., the same tissue zone) across conditions. Manual counting of a minimum of 200 cells per condition is acceptable when automated analysis is not feasible.
References and Further Reading
- NCBI Bookshelf Explore chapters on antibody based detection methods and protein interaction assays.
- EMBL EBI Training Access structured tutorials on proximity ligation assay design and data analysis.
- Galaxy Training Network Learn image analysis workflows for counting PLA dots from microscopy data.
- Bioconductor Find R packages for automated dot detection and statistical analysis of PLA experiments.
- NCBI Sequence Read Archive Repository for sequencing data that often accompanies PLA studies for validation.
- Disrupting the tumor associated TNKS USP25 protein protein interface in cancer: structural basis, druggability, and therapeutic opportunities Example of PLA used to validate a novel protein interaction.
- Detection of early stage lung adenocarcinoma using a novel extracellular vesicle and particle based blood test PLA applied to vesicle surface protein complexes.
- IP3R TRPM4 Coupling Determines the Spatial Reach of Pericyte Mediated Capillary Constriction Study showing PLA in functional tissue context.
- AMPK gamma 2 Regulates Cardiac Hypertrophy and Arrhythmias via Interacting With Myosin PLA used with appropriate controls in cardiac research.
- MFN2 Mediated MERCs Promote Odontoblast Differentiation and Dentinogenesis PLA validation of organelle contact sites.